Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1967 1
1969 1
1971 1
1973 1
1974 3
1975 1
1977 1
1978 8
1979 2
1982 2
1983 4
1984 5
1985 5
1986 1
1987 1
1988 7
1989 7
1990 8
1991 6
1992 4
1993 8
1994 5
1995 6
1996 11
1997 6
1998 10
1999 11
2000 14
2001 10
2002 26
2003 20
2004 13
2005 16
2006 21
2007 19
2008 28
2009 36
2010 37
2011 36
2012 57
2013 55
2014 39
2015 65
2016 59
2017 49
2018 54
2019 61
2020 50
2021 60
2022 47
2023 56
2024 33

Text availability

Article attribute

Article type

Publication date

Search Results

968 results

Results by year

Filters applied: . Clear all
Page 1
Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines-an exploratory sub-study of the BRACE trial.
Messina NL, Germano S, McElroy R, Bonnici R, Grubor-Bauk B, Lynn DJ, McDonald E, Nicholson S, Perrett KP, Pittet LF, Rudraraju R, Stevens NE, Subbarao K, Curtis N; BRACE trial. Messina NL, et al. EBioMedicine. 2024 Apr 23;103:105100. doi: 10.1016/j.ebiom.2024.105100. Online ahead of print. EBioMedicine. 2024. PMID: 38663355 Free PMC article.
Predictors of anastomotic leak and conduit necrosis after oesophagectomy: Results from the oesophago-gastric anastomosis audit (OGAA).
Griffiths EA; Oesophago-Gastric Anastomotic Audit (OGAA) Collaborative; Writing Committee; Data Analysis; Steering Committee; National Leads; Site Leads; Collaborators. Griffiths EA, et al. Eur J Surg Oncol. 2024 Mar 7;50(6):107983. doi: 10.1016/j.ejso.2024.107983. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 38613995
Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Mercuri E, Vilchez JJ, Boespflug-Tanguy O, Zaidman CM, Mah JK, Goemans N, Müller-Felber W, Niks EH, Schara-Schmidt U, Bertini E, Comi GP, Mathews KD, Servais L, Vandenborne K, Johannsen J, Messina S, Spinty S, McAdam L, Selby K, Byrne B, Laverty CG, Carroll K, Zardi G, Cazzaniga S, Coceani N, Bettica P, McDonald CM; EPIDYS Study Group. Mercuri E, et al. Among authors: byrne b. Lancet Neurol. 2024 Apr;23(4):393-403. doi: 10.1016/S1474-4422(24)00036-X. Lancet Neurol. 2024. PMID: 38508835 Clinical Trial.
Kenneth I. Berns, MD, PhD [1938-2024].
Byrne BJ, Flotte TR, Herzog RW, Srivastava A. Byrne BJ, et al. Hum Gene Ther. 2024 Mar;35(5-6):133-134. doi: 10.1089/hum.2024.29266.kib. Hum Gene Ther. 2024. PMID: 38497910 No abstract available.
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07).
Schoser B, Kishnani PS, Bratkovic D, Byrne BJ, Claeys KG, Díaz-Manera J, Laforêt P, Roberts M, Toscano A, van der Ploeg AT, Castelli J, Goldman M, Holdbrook F, Sitaraman Das S, Wasfi Y, Mozaffar T; ATB200-07 Study Group. Schoser B, et al. Among authors: byrne bj. J Neurol. 2024 May;271(5):2810-2823. doi: 10.1007/s00415-024-12236-0. Epub 2024 Feb 28. J Neurol. 2024. PMID: 38418563 Free PMC article. Clinical Trial.
968 results